Suman

Siam

Shradha

Ritesh

Rahul

Prem

Narayan

Himesh

Biswajit

Arti
drug

Merck’s new drug, Molnupiravir to treat Covid-19

Early findings from Phase-3 studies showed that Merck and Ridgeback Biotherapeutics’ antiviral medication molnupiravir reduced the odds of hospitalisation in COVID-19 patients with mild or severe illness, according to a press statement issued on Octob...

2 October, 2021

Read more
zydus cadila

Zydus likely to start Clinical trials for mRNA Covid vax: Reports

As per a recent report by Mint, Zydus Cadila is planning to begin clinical trials for an mRNA COVID-19 vaccine candidate. According to the article, the Ahmedabad-based business has begun seeking for partners to launch the experiment, and an official announc...

29 September, 2021

Read more
images 4

Eisai, Biogen start U.S. accelerated approval for new Alzheimer’s drug Adulhem

Eisai Co, a Japanese pharmaceutical, started the application process for its experimental treatment for early Alzheimer’s disease on Monday, following the same fast approval pathway that helped Eisai’s research partner Biogen Inc obtain U.S. cle...

28 September, 2021

Read more
skin

Ligelizumab And Omalizumab Effective For Treating Chronic Spontaneous Urticaria, JAMA findings suggest

The biologic medicines ligelizumab (72 or 240 mg) and omalizumab (300 or 600 mg) can be suggested as effective therapies for chronic spontaneous urticaria (CSU) that is not controlled by H1 antihistamines. The findings were reported in the journal JAMA Derm...

27 September, 2021

Read more

Adults need a second Covid-19 booster injection: Moderna

19 March, 2022

Prescribes Raids on Erring Pharma Firms, Health Ministry has asked ...

17 March, 2022

New York state data on Pfizer/BioNTech vaccine has EMA unconcerned

4 March, 2022

Moderna’s Covid Jab Gets EU Approval For Kids Aged 6-11

25 February, 2022

mRNA Covid vaccine scientist Dr Weissman and team working on develo...

24 February, 2022

Biological E’s Corbevax gets DCGI nod

22 February, 2022

Sources say CDL Kasauli cleared around 6.5 crore doses of Corbevax

22 February, 2022

Lupin’s antibiotic drug gets USFDA nod

18 February, 2022

Moderna expecting Covid-19 booster by August, unsure on Omicron spe...

17 February, 2022

Pfizer and BioNTech Omicron vaccine delayed: BioNTech CEO

17 February, 2022

Israel approves AstraZeneca Covid drug for people with weak immunity

16 February, 2022

Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age g...

14 February, 2022

China approves Pfizer’s Covid drug Paxlovid

12 February, 2022

Emcure Pharma arm developing Omicron specific Covid vaccine

11 February, 2022

DCGI nod to SII to make COVID vaccine against Omicron for test, ana...

8 February, 2022

Sputnik Light the second vaccine to be made available in India by D...

7 February, 2022

Pfizer asks FDA to allow Covid-19 vaccine for children under 5

2 February, 2022

Nasal Covid-19 vaccine to be a gamechanger: AIIMS epidemiologist

31 January, 2022

Moderna begins trial of Omicron specific vaccine

27 January, 2022

Covishield, Covaxin to be capped at ₹ 275 each post getting marketi...

27 January, 2022